Rhumbline Advisers Karuna Therapeutics, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$161.01 - $317.85 $50,235 - $99,169	-312 Reduced 0.66%	47,175 $14.9 Million
Q3 2023 Nov 09, 2023	BUY	$164.66 - $218.08 $61,582 - $81,561	374 Added 0.79%	47,487 $8.03 Million
Q2 2023 Aug 08, 2023	BUY	$176.32 - $240.22 $556,289 - $757,894	3,155 Added 7.18%	47,113 $10.2 Million
Q1 2023 May 11, 2023	BUY	$161.33 - $204.36 $309,269 - $391,758	1,917 Added 4.56%	43,958 $7.99 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $369,269 - $456,588	1,928 Added 4.81%	42,041 $8.26 Million
Q3 2022 Nov 10, 2022	BUY	$123.79 - $277.42 $1.12 Million - $2.51 Million	9,048 Added 29.13%	40,113 $9.02 Million
Q2 2022 Aug 11, 2022	BUY	$93.97 - $143.33 $750,350 - $1.14 Million	7,985 Added 34.6%	31,065 $3.93 Million
Q1 2022 May 12, 2022	BUY	$98.9 - $132.37 $66,164 - $88,555	669 Added 2.99%	23,080 $2.93 Million
Q4 2021 Feb 10, 2022	SELL	$110.64 - $159.4 $26,442 - $38,096	-239 Reduced 1.06%	22,411 $2.94 Million
Q3 2021 Nov 12, 2021	BUY	$101.2 - $125.87 $54,546 - $67,843	539 Added 2.44%	22,650 $2.77 Million
Q2 2021 Aug 05, 2021	BUY	$107.45 - $135.95 $403,582 - $510,628	3,756 Added 20.46%	22,111 $2.52 Million
Q1 2021 May 06, 2021	SELL	$95.46 - $133.08 $155,886 - $217,319	-1,633 Reduced 8.17%	18,355 $2.21 Million
Q4 2020 Feb 10, 2021	BUY	$75.23 - $109.23 $14,293 - $20,753	190 Added 0.96%	19,988 $2.03 Million
Q3 2020 Nov 12, 2020	SELL	$71.31 - $109.74 $215,997 - $332,402	-3,029 Reduced 13.27%	19,798 $1.53 Million
Q2 2020 Aug 13, 2020	BUY	$62.14 - $117.21 $551,181 - $1.04 Million	8,870 Added 63.55%	22,827 $2.54 Million
Q1 2020 May 06, 2020	BUY	$60.41 - $115.92 $540,246 - $1.04 Million	8,943 Added 178.36%	13,957 $1.01 Million
Q4 2019 Feb 05, 2020	BUY	$11.44 - $123.99 $57,360 - $621,685	5,014 New	5,014 $378,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account